VEXAS Syndrome-related AA Amyloidosis: a Case Report
Overview
Authors
Affiliations
A Clinicopathological Description of Kidney Features in VEXAS Syndrome.
Mathurin M, Hirsch P, Jachiet V, Hadjadj J, Le Guenno G, Heiblig M Kidney Int Rep. 2025; 10(1):260-264.
PMID: 39810778 PMC: 11725828. DOI: 10.1016/j.ekir.2024.10.026.
Nonischemic Cardiac Manifestations in VEXAS Syndrome.
Robert M, Mathian A, Lacombe V, Lobbes H, Adelaide L, Le Besnerais M JAMA Netw Open. 2024; 7(12):e2450251.
PMID: 39666342 PMC: 11638797. DOI: 10.1001/jamanetworkopen.2024.50251.
VEXAS syndrome presenting as diffuse alveolar haemorrhage.
Sofi F, Naqati S, Ahmad M, Bindroo M BMJ Case Rep. 2024; 17(3).
PMID: 38538102 PMC: 10982693. DOI: 10.1136/bcr-2023-259474.
Padureanu V, Marinas C, Bobirca A, Padureanu R, Patrascu S, Dascalu A Cureus. 2024; 16(1):e53041.
PMID: 38410307 PMC: 10895688. DOI: 10.7759/cureus.53041.
VEXAS-Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us Cohort.
Corty R, Brogan J, Byram K, Springer J, Grayson P, Bick A Arthritis Rheumatol. 2024; 76(6):942-948.
PMID: 38225170 PMC: 11410361. DOI: 10.1002/art.42802.